PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154 | +2.7% | 24,944 | +4.1% | 0.00% | – |
| Q2 2023 | $150 | +32.7% | 23,961 | +1.5% | 0.00% | – |
| Q1 2023 | $113 | -29.4% | 23,617 | +28.8% | 0.00% | – |
| Q4 2022 | $160 | -99.9% | 18,339 | +2.7% | 0.00% | – |
| Q3 2022 | $213,000 | -4.1% | 17,864 | +14.4% | 0.00% | – |
| Q2 2022 | $222,000 | -26.5% | 15,613 | +7.6% | 0.00% | – |
| Q1 2022 | $302,000 | -74.5% | 14,504 | -71.7% | 0.00% | – |
| Q4 2021 | $1,183,000 | -73.8% | 51,224 | -66.3% | 0.00% | – |
| Q3 2021 | $4,523,000 | +15.2% | 151,778 | +27.1% | 0.00% | – |
| Q1 2021 | $3,926,000 | – | 119,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |